Literature DB >> 19616246

Complications and mortality after radical cystectomy for bladder transitional cell cancer.

Giacomo Novara1, Vincenzo De Marco, Maurizio Aragona, Rafael Boscolo-Berto, Stefano Cavalleri, Walter Artibani, Vincenzo Ficarra.   

Abstract

PURPOSE: We evaluated early postoperative complications and 3-month mortality after radical cystectomy using a standardized method to report complications.
MATERIALS AND METHODS: We retrospectively collected data on all 358 consecutive patients who underwent radical cystectomy for nonmetastatic bladder transitional cell carcinoma at a tertiary academic referral center from January 2002 to December 2006. The Martin criteria were used to report complications, which were graded according to a 5-grade modification of the Clavien system.
RESULTS: A total of 231 complications occurred in 174 patients (49%), of which 13% were grades 3 to 5. The 3-month mortality rate was 3%. After evaluating the whole patient cohort American Society of Anesthesiologists score was the only covariate significantly associated with grade 3 to 5 complications on univariate analysis. Subgroup analysis limited to patients with an orthotopic ileal neobladder showed that female gender (HR 0.204, p = 0.017) and American Society of Anesthesiologists score (HR 2.851, p = 0.013) were independent predictors of grade 3 to 5 complications on multivariate analysis.
CONCLUSIONS: When applying a standardized methodology to report early morbidity, about 50% of patients undergoing radical cystectomy had complications within 3 months of surgery. Although most complications were minor, about 13% of patients experienced grade 3 to 5 events, resulting in a 3-month mortality rate of 3%. American Society of Anesthesiologists score was significantly associated with major complications, while on subgroup analysis in patients who received an orthotopic ileal neobladder female gender was also an independent predictor of major complications.

Entities:  

Mesh:

Year:  2009        PMID: 19616246     DOI: 10.1016/j.juro.2009.05.032

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  54 in total

1.  Blood transfusion and hemostatic agents used during radical cystectomy.

Authors:  Nahid Punjani; Luke T Lavallée; Franco Momoli; Dean Fergusson; Kelsey Witiuk; Ranjeeta Mallick; Christopher Morash; Ilias Cagiannos; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

2.  Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort.

Authors:  Florian Roghmann; Andreas Becker; Quoc-Dien Trinh; Orchidee Djahangirian; Orchidee Djahagirian; Zhe Tian; Malek Meskawi; Shahrokh F Shariat; Markus Graefen; Pierre Karakiewicz; Joachim Noldus; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

3.  The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.

Authors:  Adam C Reese; Mark W Ball; Nilay Gandhi; Michael A Gorin; George J Netto; Trinity J Bivalacqua; Mark P Schoenberg
Journal:  Urology       Date:  2014-08       Impact factor: 2.649

4.  Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

Authors:  Victor A McPherson; George Rodrigues; Glenn Bauman; Eric Winquist; Joseph Chin; Jonathan Izawa; Kylea Potvin; Scott Ernst; Varagur Venkatesan; Tracy Sexton; Belal Ahmad; Nicholas Power
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

5.  Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Authors:  Jennifer M Taylor; Andrew Feifer; Caroline J Savage; Alexandra C Maschino; Melanie Bernstein; Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2011-07-01       Impact factor: 5.588

6.  [Complications of radical retropubic prostatectomies based on the Martin criteria].

Authors:  B Löppenberg; J Noldus; J Palisaar
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

7.  [Cystectomy in elderly patients: analysis of complications using the Clavien-Dindo classification].

Authors:  F Roghmann; J Noldus; C von Bodman; A Holz; M Brock; J Palisaar
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

8.  Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-making.

Authors:  Stephen B Williams; Jinhai Huo; Yiyi Chu; Jacques G Baillargeon; Timothy Daskivich; Yong-Fang Kuo; Christopher D Kosarek; Simon P Kim; Eduardo Orihuela; Douglas S Tyler; Stephen J Freedland; Ashish M Kamat
Journal:  Urology       Date:  2017-08-25       Impact factor: 2.649

9.  Identification of underserved areas for urologic cancer care.

Authors:  Matthew Mossanen; Jason Izard; Jonathan L Wright; Jonathan D Harper; Michael P Porter; Kenn B Daratha; Sarah K Holt; John L Gore
Journal:  Cancer       Date:  2014-02-12       Impact factor: 6.860

10.  Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis.

Authors:  Michael Ahdoot; Leanne Almario; Hiwot Araya; Jonas Busch; Simon Conti; Mark L Gonzalgo
Journal:  World J Urol       Date:  2014-01-28       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.